Cardlytics, Inc. (NASDAQ:CDLX) Q4 2025 Earnings Call Transcript
Operator: Good evening, ladies and gentlemen, and welcome to the Cardlytics Fourth Quarter Fiscal Year 2025 Earnings Conference Call.
Cardlytics Inc. (CDLX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.58 | 40,000 | $143,200.00 | 40,000 | 2024-08-12 | Filing | |
| $3.59 | 10,000 | $35,900.00 | 10,000 | 2024-08-12 | Filing | |
| $3.49 | 14,000 | $48,860.00 | 67,593 | 2024-08-12 | Filing | |
| $8.99 | 3,746 | $33,661.56 | 6,464,859 | 2024-05-13 | Filing | |
| $8.79 | 100,000 | $878,540.00 | 6,461,113 | 2024-05-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.19 | 69,833 | $82,891.77 | 987,387 | 2026-04-06 | Filing | |
| $1.04 | 54,225 | $56,502.45 | 1,057,220 | 2026-04-02 | Filing | |
| $0.99 | 62,549 | $61,923.51 | 1,111,445 | 2026-04-01 | Filing | |
| $0.99 | 40,296 | $39,893.04 | 167,856 | 2026-04-01 | Filing | |
| $0.93 | 45,159 | $41,817.23 | 659,644 | 2026-02-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,290,000 | $9,236,624 | 0.21% | |
| 2. | 12,379,000 | $3,686,114 | 0.04% | |
| 3. | 2,063,367 | $2,166,535 | 0% | |
| 4. | 437,412 | $459,283 | 0% | |
| 5. | 324,700 | $340,935 | 0% |
News See All
Cardlytics, Inc. (NASDAQ:CDLX) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Q3 2025 Cardlytics, Inc. Earnings Conference Call. [Operator Instructions] This call is being recorded on November 5, 2025.
Cardlytics, Inc. (NASDAQ:CDLX) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Second Quarter 2025 Cardlytics, Inc. Earnings Conference Call.
Cardlytics, Inc. (NASDAQ:CDLX) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Cardlytics Inc. Q1 2025 Earnings Conference Call.
Cardlytics, Inc. (NASDAQ:CDLX) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Cardlytics Fourth Quarter Fiscal Year 2024 Earnings Conference Call. At this time, all lines are in listen-only mode.
15 Best Advertising Stocks to Buy According to Hedge Funds
Ad spending in 2024 received a significant boost from recurring events such as the US election and the Olympics, and experts believe that these spending patterns are likely to add billions to the market...
Cardlytics, Inc. (NASDAQ:CDLX) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Cardlytics Third Quarter 2024 Financial Results Call. At this time, all participants are in a listen-only mode.
Cardlytics, Inc. (CDLX): A Bull Case Theory
We came across a bullish thesis on Cardlytics, Inc. (CDLX) on Value Degen’s Substack by Unemployed Value Degen and Alejandro Yela. In this article, we will summarize the bulls’ thesis on CDLX.
10 Worst Marketing Stocks to Buy
The marketing and advertising industry is a vital part of our economy, playing multifaceted roles in facilitating market efficiency, nurturing creativity and innovation, and driving growth.
Cardlytics, Inc. (NASDAQ:CDLX) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Cardlytics Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center